EP0722339A4 - VACCINES STRAINS OF SEROGROUP 01 (CVD111) AND NON-01 (CVD112 AND CVD112RM) OF $ i (VIBRIO CHOLERAE) AND METHODS OF MAKING SAID STRAINS - Google Patents

VACCINES STRAINS OF SEROGROUP 01 (CVD111) AND NON-01 (CVD112 AND CVD112RM) OF $ i (VIBRIO CHOLERAE) AND METHODS OF MAKING SAID STRAINS

Info

Publication number
EP0722339A4
EP0722339A4 EP94930665A EP94930665A EP0722339A4 EP 0722339 A4 EP0722339 A4 EP 0722339A4 EP 94930665 A EP94930665 A EP 94930665A EP 94930665 A EP94930665 A EP 94930665A EP 0722339 A4 EP0722339 A4 EP 0722339A4
Authority
EP
European Patent Office
Prior art keywords
cvd112rm
cvd112
cvd111
methods
making same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94930665A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP0722339A1 (en
Inventor
James B Kaper
Myron M Levine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Maryland at Baltimore
Original Assignee
University of Maryland at Baltimore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Maryland at Baltimore filed Critical University of Maryland at Baltimore
Publication of EP0722339A1 publication Critical patent/EP0722339A1/en
Publication of EP0722339A4 publication Critical patent/EP0722339A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP94930665A 1993-10-08 1994-10-07 VACCINES STRAINS OF SEROGROUP 01 (CVD111) AND NON-01 (CVD112 AND CVD112RM) OF $ i (VIBRIO CHOLERAE) AND METHODS OF MAKING SAID STRAINS Withdrawn EP0722339A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13343993A 1993-10-08 1993-10-08
US13343893A 1993-10-08 1993-10-08
US133438 1993-10-08
US133439 1993-10-08
PCT/US1994/011424 WO1995010300A1 (en) 1993-10-08 1994-10-07 Vibrio cholerae 01 (cvd111) and non-01 (cvd112 and cvd112rm) serogroup vaccine strains and methods of making same

Publications (2)

Publication Number Publication Date
EP0722339A1 EP0722339A1 (en) 1996-07-24
EP0722339A4 true EP0722339A4 (en) 2001-05-23

Family

ID=26831377

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94930665A Withdrawn EP0722339A4 (en) 1993-10-08 1994-10-07 VACCINES STRAINS OF SEROGROUP 01 (CVD111) AND NON-01 (CVD112 AND CVD112RM) OF $ i (VIBRIO CHOLERAE) AND METHODS OF MAKING SAID STRAINS

Country Status (8)

Country Link
EP (1) EP0722339A4 (ru)
JP (1) JP3379582B2 (ru)
KR (1) KR100348156B1 (ru)
CN (1) CN1104907C (ru)
AU (1) AU699912B2 (ru)
CA (1) CA2173606A1 (ru)
RU (1) RU2140981C1 (ru)
WO (1) WO1995010300A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0887403A3 (en) * 1997-06-27 2000-12-06 Chiron S.P.A. Attenuated Vibrio cholerae strains
EP0928831B1 (en) * 1997-12-10 2006-05-03 Council of Scientific and Industrial Research Cholera organisms, vaccines and preparation thereof
CN111826316A (zh) * 2020-07-28 2020-10-27 上海海洋大学 耐受重金属的非o1/o139型霍乱弧菌菌株及应用
CN111662855A (zh) * 2020-07-28 2020-09-15 上海海洋大学 耐受抗菌素和重金属的非o1/o139型霍乱弧菌菌株及应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018979A1 (en) * 1990-06-05 1991-12-12 University Of Maryland At Baltimore Method of isolating restriction fragment deletions in vibrio cholerae, and products thereof
US5135862A (en) * 1983-03-04 1992-08-04 University Of Maryland Method of isolating restriction fragment deletions in vibrio cholerae, products thereof
WO1994001533A1 (en) * 1992-07-06 1994-01-20 President And Fellows Of Harvard College Deletion mutants as vaccines for cholera

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135862A (en) * 1983-03-04 1992-08-04 University Of Maryland Method of isolating restriction fragment deletions in vibrio cholerae, products thereof
WO1991018979A1 (en) * 1990-06-05 1991-12-12 University Of Maryland At Baltimore Method of isolating restriction fragment deletions in vibrio cholerae, and products thereof
WO1994001533A1 (en) * 1992-07-06 1994-01-20 President And Fellows Of Harvard College Deletion mutants as vaccines for cholera

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHOLERA WORKING GROUP: "Large epidemic of cholera-like disease in Bangladesh caused by vibrio 0139 synonym Bengal", THE LANCET, vol. 342, 14 August 1993 (1993-08-14), pages 387 - 390, XP000973630 *
LEVINE M M ET AL: "RECOMBINANT LIVE CHOLERA VACCINES", VIBRIO CHOLERAE AND CHOLERA: MOLECULAR TO GLOBAL PERSPECTIVES,US,AMERICAN SOCIETY FOR MICROBIOLOGY,, PAGE(S) 395-413, XP000886576 *
PEARSON ET AL: "CTX genetic element encodes a site-specific recomnation system and an intestinal colonization factor", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA,US,NATIONAL ACADEMY OF SCIENCE. WASHINGTON, vol. 90, 1 April 1993 (1993-04-01), pages 3750 - 3754, XP002085116, ISSN: 0027-8424 *
See also references of WO9510300A1 *
TACKET ET AL: "Initial Clinical Studies of CVD 112 Vibrio Cholerae O139 Live Oral Vaccine: Safety and Efficacy against Experimental Challenge", THE JOURNAL OF INFECTIOUS DISEASES, vol. 172, 1995, pages 883 - 886, XP000973598 *

Also Published As

Publication number Publication date
RU2140981C1 (ru) 1999-11-10
JPH09504430A (ja) 1997-05-06
AU699912B2 (en) 1998-12-17
CN1104907C (zh) 2003-04-09
EP0722339A1 (en) 1996-07-24
WO1995010300A1 (en) 1995-04-20
CA2173606A1 (en) 1995-04-20
KR100348156B1 (ko) 2003-01-06
KR960704571A (ko) 1996-10-09
CN1142774A (zh) 1997-02-12
JP3379582B2 (ja) 2003-02-24
AU7971494A (en) 1995-05-04

Similar Documents

Publication Publication Date Title
BG101901A (en) 2-methyl-thieno-benzodiazepine formulation for oral application
ZA944773B (en) Sustained release compositions and a method of preparing pharmaceutical compositions and a method of preparing pharmaceutical compositions
PL313433A1 (en) Derivatives of benzazepin-, benzoxazepin- and benzothiazepin-n-acetic acids, method of obtaining them and therapeutic agents containing such derivatives
EP0813533A4 (en) N-CYCLOALKYLMETHYL-1H-PYRAZOLO 3,4-b] SUBSTITUTED QUINOLIN-4-AMINES AND COMPOSITIONS AND METHODS OF USE THEREOF
EP0567131A3 (en) Oxygen-enriched combustion method
PL311036A1 (en) Method of obtaining an anticarcinogenic vaccine
PL314640A1 (en) Method of vaccinating against coccodiosis
EP0732351A3 (de) Verfahren und Vorrichtung zur Herstellung von Polyamiden
ZA9410056B (en) Indoline derivatives method of preparation and use
PL312354A1 (en) 2,9-disubstituted purin-6-ones method of obtaining and therapeutic agents containing them
HU900632D0 (en) Pipe joint and process for producing of it
ZA949296B (en) Sustained release compositions and a method of preparing pharmaceutical compositions.
GR3034020T3 (en) Maltitol composition and its process of preparation
IL112053A0 (en) Methods of inhibiting turner's syndrome
EP0722339A4 (en) VACCINES STRAINS OF SEROGROUP 01 (CVD111) AND NON-01 (CVD112 AND CVD112RM) OF $ i (VIBRIO CHOLERAE) AND METHODS OF MAKING SAID STRAINS
HU9502503D0 (en) 2,3-cyclic-condensed-1,4-dihydro-pyridine derivatives, process for producing them and pharmaceutical use of them
ZA9410004B (en) Aminosulphonyl-phenyl-1h-pyrrole derivatives method of their preparation and their use
AU1307592A (en) Improvements in or relating to methods of and/or apparatus for forming joints
CS274701B2 (en) Method of polymere incrustations' forming impedment
GB9210984D0 (en) Protection of pipe joints
EP0761719A3 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
NO942531D0 (no) Fremgangsmåte for fremstilling av 3-acylöstratriener og acylbenzener
SG43216A1 (en) Process for the preparation of diphenylamine
NO971419L (no) Fremgangsmåte for fremstilling av 1,3-alkendioler og 3-hydroksyaldehyder
PL303822A1 (en) Therapeutic compositions containing ipsapyrone and method of obtaining them

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19951121

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20010405

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20010621